Differential role of transient receptor potential channels in Ca 2+ entry and proliferation of prostate cancer epithelial cells

Cancer Research

Volumn 66, Issue 4, 2006, Pages 2038-2047

  Thebault, Stephanie ^a   Flourakis, Matthieu ^a   Vanoverberghe, Karine ^a   Vandermoere, Franck ^b   Roudbaraki, Morad ^a   Lehen'kyi, V'yacheslav ^a   Slomianny, Christian ^a   Beck, Benjamin ^a   Mariot, Pascal ^a   Bonnal, Jean Louis ^a   Mauroy, Brigitte ^a   Shuba, Yaroslav ^a,c   Capiod, Thierry ^a   Skryma, Roman ^a   Prevarskaya, Natalia ^a  

^a Université des Sciences et Technologies de Lille   (France)

^b CNRS   (France)

^c INSTITUTE OF HYDROBIOLOGY   (Ukraine)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; CALCIUM CHANNEL STIMULATING AGENT; CALCIUM ION; PURINE P2 RECEPTOR; TRANSCRIPTION FACTOR NFAT; TRANSIENT RECEPTOR POTENTIAL CANONICAL 6 CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; EPITHELIUM CELL; GENE SILENCING; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN ANALYSIS;

ADENOSINE TRIPHOSPHATE; ADRENERGIC ALPHA-AGONISTS; CALCIUM; CALCIUM SIGNALING; CELL GROWTH PROCESSES; EPITHELIAL CELLS; HUMANS; MALE; NF-KAPPA B; NFATC TRANSCRIPTION FACTORS; PHENYLEPHRINE; PROSTATIC NEOPLASMS; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, PURINERGIC; TRANSIENT RECEPTOR POTENTIAL CHANNELS; TRPC CATION CHANNELS; UP-REGULATION;

EID: 33644515955     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-0376     Document Type: Article

References (46)

1. Berridge MJ, Bootman MD, Lipp P. Calcium: a life and death signal. Nature 1998;395:645-8.
2. Clapham DE. Calcium signaling. Cell 1995;80:259-68.
3. 2+ entry. Cell 2002;111:529-41.
4. Putney JW, Jr., Broad LM, Braun FJ, Lievremont JP, Bird GS. Mechanisms of capacitative calcium entry. J Cell Sci 2001;114:2223-9.
5. Caine M. Alpha-adrenergic blockers for the treatment of benign prostatic hyperplasia. Urol Clin North Am 1990;17:641-9.
6. Kyprianou N, Chon J, Benning CM. Effects of alpha(1)-adrenoceptor (alpha(1)-AR) antagonists on cell proliferation and apoptosis in the prostate: therapeutic implications in prostatic disease. Prostate Suppl 2000;9:42-6.
7. Kyprianou N, Benning CM. Suppression of human prostate cancer cell growth by alpha1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis. Cancer Res 2000;60:4550-5.
8. Benning CM, Kyprianou N. Quinazoline-derived alpha1-adrenoceptor antagonists induce prostate cancer cell apoptosis via an alpha1-adrenoceptor- independent action. Cancer Res 2002;62:597-602.
9. Horoszewicz JS, Leong SS, Kawinski E, et al. LNCaP model of human prostatic carcinoma. Cancer Res 1983;43:1809-18.
10. Thebault S, Roudbaraki M, Sydorenko V, et al. Alpha1-adrenergic receptors activate Ca(2+)-permeable cationic channels in prostate cancer epithelial cells. J Clin Invest 2003;111:1691-701.
11. Vanoverberghe K, Mariot P, Vanden Abeele F, Delcourt P, Parys JB, Prevarskaya N. Mechanisms of ATP-induced calcium signaling and growth arrest in human prostate cancer cells. Cell Calcium 2003;34:75-85.
12. 2+. Pharmacol Rev 1988;40:87-119.
13. Marshall I, Burt RP, Chapple CR. Signal transduction pathways associated with alpha1-adrenoceptor subtypes in cells and tissues including human prostate. Eur Urol 1999;36:42-7; discussion 65.
14. Clapham DE. TRP channels as cellular sensors. Nature 2003;426:517-24.
15. Golovina VA. Cell proliferation is associated with enhanced capacitative Ca(2+) entry in human arterial myocytes. Am J Physiol 1999;277:C343-9.
16. Golovina VA, Platoshyn O, Bailey CL, et al. Upregulated TRP and enhanced capacitative Ca(2+) entry in human pulmonary artery myocytes during proliferation. Am J Physiol Heart Circ Physiol 2001;280:H746-55.
17. Inoue R, Okada T, Onoue H, et al. The transient receptor potential protein homologue TRP6 is the essential component of vascular alpha(1)-adrenoceptor-activated Ca(2+)- permeable cation channel. Circ Res 2001;88:325-32.
18. Montell C. Physiology, phylogeny, and functions of the TRP superfamily of cation channels. Sci STKE 2001;2001:RE1.
19. Crabtree GR. Calcium, calcineurin, and the control of transcription. J Biol Chem 2001;276:2313-6.
20. Li X, Stark GR. NFkappaB-dependent signaling pathways. Exp Hematol 2002;30:285-96.
21. van Leenders GJ, Aalders TW, Hulsbergen-van de Kaa CA, Ruiter DJ, Schalken JA. Expression of basal cell keratins in human prostate cancer metastases and cell lines. J Pathol 2001;195:563-70.
22. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440-50.
23. 2+ current in human prostate cancer LNCaP cells: involvement in apoptosis. J Physiol 2000;527 Pt 1:71-83.
24. Skryma RN, Prevarskaya NB, Dufy-Barbe L, Odessa MF, Audin J, Dufy B. Potassium conductance in the androgen-sensitive prostate cancer cell line, LNCaP: involvement in cell proliferation. Prostate 1997;33:112-22.
25. Vanden Abeele F, Skryma R, Shuba Y, et al. Bcl-2-dependent modulation of Ca(2+) homeostasis and store-operated channels in prostate cancer cells. Cancer Cell 2002;1:169-79.
26. 2+ transporter type 1. J Biol Chem 2003;278:15381-9.
27. 2+-permeable cationic channels in LNCaP human prostate cancer epithelial cells. J Physiol 2003;548:823-36.
28. Fang WG, Pirnia F, Bang YJ, Myers CE, Trepel JB. P2-purinergic receptor agonists inhibit the growth of androgen-independent prostate carcinoma cells. J Clin Invest 1992;89:191-6.
29. Thebault S, Zholos A, Enfissi A, et al. Receptor-operated Ca(2+) entry mediated by TRPC3/TRPC6 proteins in rat prostate smooth muscle (PS1) cell line. J Cell Physiol 2005;204:320-8.
30. 2+ channels with different activation modes and molecular origin in LNCaP human prostate cancer epithelial cells. J Biol Chem 2004;279:30326-37.
31. Sotillo R, Renner O, Dubus P, et al. Cooperation between Cdk4 and p27kip1 in tumor development: a preclinical model to evaluate cell cycle inhibitors with therapeutic activity. Cancer Res 2005;65:3846-52.
32. Pattni K, Millard TH, Banting G. Calpain cleavage of the B isoform of Ins(1,4,5)P3 3-kinase separates the catalytic domain from the membrane anchoring domain. Biochem J 2003;375:643-51.
33. Sims CE, Allbritton NL. Metabolism of inositol 1,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate by the oocytes of Xenopus laevis. J Biol Chem 1998;273:4052-8.
34. Allbritton NL, Meyer T, Stryer L. Range of messenger action of calcium ion and inositol 1,4,5-trisphosphate. Science 1992;258:1812-5.
35. Wang SS, Alousi AA, Thompson SH. The lifetime of inositol 1,4,5-trisphosphate in single cells. J Gen Physiol 1995;105:149-71.
36. Fujii R, Imahori Y, Ido T, et al. [Carbon-11 labeled diacylglycerol for signal transduction imaging by positron CT: evaluation of the quality and safety for clinical use]. Kaku Igaku 1995;32:191-8.
37. Dolmetsch RE, Xu K, Lewis RS. Calcium oscillations increase the efficiency and specificity of gene expression. Nature 1998;392:933-6.
38. Mignen O, Thompson JL, Shuttleworth TJ. Calcineurin directs the reciprocal regulation of calcium entry pathways in nonexcitable cells. J Biol Chem 2003;278:40088-96.
39. 2+ entry pathways. J Biol Chem 2001;276:35676-83.
40. Beech DJ, Xu SZ, McHugh D, Flemming R. TRPC1 store-operated cationic channel subunit. Cell Calcium 2003;33:433-40.
41. 2+-permeable nonselective cation channels. Cell Calcium 2003;33:441-50.
42. Trebak M, Bird GS, McKay RR, Birnbaumer L, Putney JW, Jr. Signaling mechanism for receptor-activated TRPC3 channels. J Biol Chem 2003;278:16244-52.
43. Hofmann T, Obukhov AG, Schaefer M, Harteneck C, Gudermann T, Schultz G. Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. Nature 1999;397:259-63.
44. Estacion M, Li S, Sinkins WG, et al. Activation of human TRPC6 channels by receptor stimulation. J Biol Chem 2004;279:22047-56.
45. 2+ entry and attenuates pulmonary artery smooth muscle cell proliferation. Am J Physiol Lung Cell Mol Physiol 2002;283:L144-55.
46. Yu Y, Sweeney M, Zhang S, et al. PDGF stimulates pulmonary vascular smooth muscle cell proliferation by upregulating TRPC6 expression. Am J Physiol Cell Physiol 2003;284:C316-30.